The CD34+/CD38- cells in BM samples at CR after chemotherapy for transformed AML were sorted as single cells and analyzed for JAK2V617F, TP53R248W, TP53V173L, ZNF143S286R, UBR4R450H, and SMARCC2D381E mutations. This evidence concerns the gene CD38 and acute myeloid leukemia.